|
MRI News Service:
'Gadolinium' p5 |
|
|
|
 |
 | | | ''According to a new market research report Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium and Barium), By Technique (X-ray, CT, MRI, Cath Lab and Ultrasound) and By Application (Radiology, Interventional Radiology and ...' | | Monday, 6 July 2015 by www.prnewswire.com |
|
|
|
| | | ''Long scan times of 3D volumetric MR acquisitions usually necessitate ultrafast in vivo gradient-echo acquisitions, which are intrinsically susceptible to magnetic field inhomogeneities. This is especially problematic for contrast-enhanced (CE)-MRI ...' | | | Tuesday, 27 May 2014 by www.nature.com | |
|
|
|
| | | ''Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine ...' | | | Friday, 22 March 2013 by www.itnonline.com | |
|
|
|
| | | ''To produce sharper images of organs through magnetic resonance imaging, doctors and researchers often inject patients with so-called contrast agents. The most commonly used agents contain the metal gadolinium. Researchers are looking for all-organic ...' | | | Monday, 24 September 2012 by cen.acs.org | |
|
|
|
| | | ''Paramagnetic and superparamagnetic metals are used as contrast materials for magnetic resonance (MR) based techniques. Lanthanide metal gadolinium (Gd) has been the most widely explored, predominant paramagnetic contrast agent until the discovery and ...' | | | Friday, 4 November 2011 by www.ncbi.nlm.nih.gov | |
|
|
|
| | | ''Ultra-small gadolinium oxide nanoparticles (Gd2O3) are being developed as positive contrast agents for molecular and cellular magnetic resonance imaging (MRI). Recent studies have demonstrated that these particles can be used to label and track cells in ...' | | | Thursday, 29 September 2011 by nanotechweb.org | |
|
|
|
| | | ''Magnetic resonance imaging (MRI) using gadolinium-based contrast agents is safe in intensive care unit (ICU) patients at high risk for kidney injury, according to the results of a small retrospective study presented in poster format at the Society for ...' | | | Monday, 18 April 2011 by www.renalandurologynews.com | |
|
|
|
| | | ''Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved Bayer's gadobutrol injection Gadavist™ (gadobutrol), a 1.0 molar macrocyclic gadolinium-based contrast agent (GBCA) for intravenous use in ...' | | | Tuesday, 15 March 2011 by viva.vita.bayerhealthcare.de | |
|
|
|
| | | ''For spotting the tiniest metastases inside the liver, MRI with the liver-specific gadolinium-based contrast agent Primovist (gadoxetic acid) was far and away the top choice of surgeons in an eight-country multicenter study. The surgeons were given a ...' | | | Sunday, 6 March 2011 by www.searchmedica.com | |
|
|
|
| | | ''The overall objective of this study was to develop a nanoparticle formulation for dual modality imaging of head and neck cancer. Here, we report the synthesis and characterization of polymeric phospholipid-based nanomicelles encapsulating near-infrared ...' | | | Saturday, 27 November 2010 by 7thspace.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
The most exciting phrase to hear in science, the one that heralds new
discoveries, is not 'Eureka!' (I found it!) but 'That's funny ...'
-
Isaac Asimov |
|
|
News
top
